Annual sales of cariprazine likely to reach targets
…between the two companies, Gedeon Richter, the prominent Hungarian pharmaceutical manufacturer, is entitled to royalty payments from US sales of Vraylar. In the first three quarters of 2018, the company received $65m (€55m) from Allergan, and this accounts for 5.1% of its sales revenues.
Sign up now to open the entire news item.You are allowed to open only one news item from PMR websites.
(to send requested information)
(required for new e-mails only)